SARS-CoV-2 another kind of liver aggressor, how does it do that?

Clinical manifestations of SARS-CoV-2 infection include more frequently fever and cough, but complications (such as pneumonia, respiratory distress syndrome, and multiorgan failure) can occur in persons with additional comorbidities. Liver dysfunction is one of the most striking affections among pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano-Sepulveda, Sonia A., Galan-Huerta, Kame, Martínez-Acuña, Natalia, Arellanos-Soto, Daniel, Rivas-Estilla, Ana María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2020
Materias:
Opinions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445466/
https://www.ncbi.nlm.nih.gov/pubmed/32858226
http://dx.doi.org/10.1016/j.aohep.2020.08.062
_version_ 1783573993558638592
author Lozano-Sepulveda, Sonia A.
Galan-Huerta, Kame
Martínez-Acuña, Natalia
Arellanos-Soto, Daniel
Rivas-Estilla, Ana María
author_facet Lozano-Sepulveda, Sonia A.
Galan-Huerta, Kame
Martínez-Acuña, Natalia
Arellanos-Soto, Daniel
Rivas-Estilla, Ana María
author_sort Lozano-Sepulveda, Sonia A.
collection PubMed
description Clinical manifestations of SARS-CoV-2 infection include more frequently fever and cough, but complications (such as pneumonia, respiratory distress syndrome, and multiorgan failure) can occur in persons with additional comorbidities. Liver dysfunction is one of the most striking affections among patients suggesting that SARS-CoV-2 may represent a new king of liver aggressor. However, the molecular process underlying this phenomenon is still unclear. In this work, we overview the most recent findings between the molecular biology of the virus, pathogenic mechanisms, and its relationship to liver disease observed in patients.
format Online
Article
Text
id pubmed-7445466
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-74454662020-08-26 SARS-CoV-2 another kind of liver aggressor, how does it do that? Lozano-Sepulveda, Sonia A. Galan-Huerta, Kame Martínez-Acuña, Natalia Arellanos-Soto, Daniel Rivas-Estilla, Ana María Ann Hepatol Opinions Clinical manifestations of SARS-CoV-2 infection include more frequently fever and cough, but complications (such as pneumonia, respiratory distress syndrome, and multiorgan failure) can occur in persons with additional comorbidities. Liver dysfunction is one of the most striking affections among patients suggesting that SARS-CoV-2 may represent a new king of liver aggressor. However, the molecular process underlying this phenomenon is still unclear. In this work, we overview the most recent findings between the molecular biology of the virus, pathogenic mechanisms, and its relationship to liver disease observed in patients. Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2020 2020-08-25 /pmc/articles/PMC7445466/ /pubmed/32858226 http://dx.doi.org/10.1016/j.aohep.2020.08.062 Text en © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Opinions
Lozano-Sepulveda, Sonia A.
Galan-Huerta, Kame
Martínez-Acuña, Natalia
Arellanos-Soto, Daniel
Rivas-Estilla, Ana María
SARS-CoV-2 another kind of liver aggressor, how does it do that?
title SARS-CoV-2 another kind of liver aggressor, how does it do that?
title_full SARS-CoV-2 another kind of liver aggressor, how does it do that?
title_fullStr SARS-CoV-2 another kind of liver aggressor, how does it do that?
title_full_unstemmed SARS-CoV-2 another kind of liver aggressor, how does it do that?
title_short SARS-CoV-2 another kind of liver aggressor, how does it do that?
title_sort sars-cov-2 another kind of liver aggressor, how does it do that?
topic Opinions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445466/
https://www.ncbi.nlm.nih.gov/pubmed/32858226
http://dx.doi.org/10.1016/j.aohep.2020.08.062
work_keys_str_mv AT lozanosepulvedasoniaa sarscov2anotherkindofliveraggressorhowdoesitdothat
AT galanhuertakame sarscov2anotherkindofliveraggressorhowdoesitdothat
AT martinezacunanatalia sarscov2anotherkindofliveraggressorhowdoesitdothat
AT arellanossotodaniel sarscov2anotherkindofliveraggressorhowdoesitdothat
AT rivasestillaanamaria sarscov2anotherkindofliveraggressorhowdoesitdothat

Ejemplares similares